NO20062434L - Sammensetninger og fremgangsmater til a kontrollere legemiddeltap og -levering i transdermale legemiddelleveringssystemer - Google Patents
Sammensetninger og fremgangsmater til a kontrollere legemiddeltap og -levering i transdermale legemiddelleveringssystemerInfo
- Publication number
- NO20062434L NO20062434L NO20062434A NO20062434A NO20062434L NO 20062434 L NO20062434 L NO 20062434L NO 20062434 A NO20062434 A NO 20062434A NO 20062434 A NO20062434 A NO 20062434A NO 20062434 L NO20062434 L NO 20062434L
- Authority
- NO
- Norway
- Prior art keywords
- drug
- delivery
- compositions
- transdermal
- methods
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000013271 transdermal drug delivery Methods 0.000 title 1
- 239000000853 adhesive Substances 0.000 abstract 2
- 230000001070 adhesive effect Effects 0.000 abstract 2
- 230000037317 transdermal delivery Effects 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 238000012377 drug delivery Methods 0.000 abstract 1
- 210000004877 mucosa Anatomy 0.000 abstract 1
- 229940100640 transdermal system Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51530603P | 2003-10-28 | 2003-10-28 | |
PCT/US2004/035556 WO2005042055A2 (en) | 2003-10-28 | 2004-10-28 | Transdermal drug delivery device |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20062434L true NO20062434L (no) | 2006-07-14 |
Family
ID=34549389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20062434A NO20062434L (no) | 2003-10-28 | 2006-05-29 | Sammensetninger og fremgangsmater til a kontrollere legemiddeltap og -levering i transdermale legemiddelleveringssystemer |
Country Status (19)
Country | Link |
---|---|
US (3) | US8703175B2 (es) |
EP (1) | EP1682061B1 (es) |
JP (2) | JP2007509951A (es) |
KR (1) | KR20060114338A (es) |
CN (1) | CN100457064C (es) |
AU (1) | AU2004285505B2 (es) |
BR (1) | BRPI0416063A (es) |
CA (1) | CA2542778C (es) |
ES (1) | ES2626784T3 (es) |
GE (1) | GEP20084561B (es) |
IL (1) | IL174894A0 (es) |
ME (2) | ME00114B (es) |
NO (1) | NO20062434L (es) |
NZ (1) | NZ546992A (es) |
RS (1) | RS20060332A (es) |
RU (1) | RU2356580C2 (es) |
UA (1) | UA84303C2 (es) |
WO (1) | WO2005042055A2 (es) |
ZA (1) | ZA200603300B (es) |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030170195A1 (en) * | 2000-01-10 | 2003-09-11 | Noven Pharmaceuticals, Inc. | Compositions and methods for drug delivery |
DE60017831T3 (de) * | 1999-01-14 | 2009-12-17 | Noven Pharmaceuticals, Inc., Miami | Dermale zusammensetzungen |
US6682757B1 (en) * | 2000-11-16 | 2004-01-27 | Euro-Celtique, S.A. | Titratable dosage transdermal delivery system |
WO2005025549A2 (en) * | 2003-09-10 | 2005-03-24 | Noven Pharmaceuticals, Inc. | Multi-layer transdermal drug delivery device |
CA2546200A1 (en) * | 2003-11-18 | 2005-06-02 | 3M Innovative Properties Company | Olanzapine containing transdermal drug delivery compositions |
US7780981B2 (en) | 2004-09-13 | 2010-08-24 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery |
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
WO2006041907A2 (en) | 2004-10-08 | 2006-04-20 | Noven Pharmaceuticals, Inc. | Transdermal delivery of estradiol |
WO2006041911A2 (en) | 2004-10-08 | 2006-04-20 | Noven Pharmaceuticals, Inc. | Device transdermal administration of drugs including acrylic polymers |
KR100764679B1 (ko) * | 2005-07-22 | 2007-10-09 | 익수제약 주식회사 | 파록세틴을 함유하는 경피투여용 패취제 |
EP1968539A2 (en) * | 2005-12-13 | 2008-09-17 | Biodelivery Sciences International, Inc. | Abuse resistant transmucosal drug delivery device |
DE102006026060B4 (de) * | 2006-01-12 | 2013-01-31 | Lts Lohmann Therapie-Systeme Ag | Transdermales Therapeutisches System enthaltend als Wirkstoff Nikotin und Verfahren zur Herstellung solcher Systeme |
EP2010156B1 (en) | 2006-03-24 | 2016-11-16 | Auxilium International Holdings, Inc. | Stabilized compositions containing alkaline labile drugs |
CN101489756B (zh) * | 2006-03-24 | 2013-08-07 | 奥克思利尤姆国际控股公司 | 热熔挤出层压材料的制备方法 |
WO2007112287A2 (en) * | 2006-03-24 | 2007-10-04 | Auxilium Pharmaceuticals, Inc. | Hme transdermal compositions containing testosterone |
EP3067044B1 (en) | 2006-07-21 | 2019-03-27 | BioDelivery Sciences International, Inc. | Transmucosal delivery devices with enhanced uptake |
US20090263346A1 (en) * | 2006-12-05 | 2009-10-22 | David Taft | Systems and methods for delivery of drugs |
US20100004124A1 (en) * | 2006-12-05 | 2010-01-07 | David Taft | Systems and methods for delivery of materials for agriculture and aquaculture |
EP2500015A1 (en) * | 2006-12-05 | 2012-09-19 | Landec Corporation | Delivery of drugs |
US8399007B2 (en) * | 2006-12-05 | 2013-03-19 | Landec Corporation | Method for formulating a controlled-release pharmaceutical formulation |
US20090246155A1 (en) * | 2006-12-05 | 2009-10-01 | Landec Corporation | Compositions and methods for personal care |
BRPI0814697B8 (pt) | 2007-07-10 | 2021-05-25 | Agile Therapeutics Inc | dispositivo de liberação de fármacos |
WO2009026135A2 (en) * | 2007-08-17 | 2009-02-26 | Alza Corporation | Controlled transdermal bisoprolol delivery system |
WO2009026133A2 (en) * | 2007-08-17 | 2009-02-26 | Alza Corporation | Transdermal bisoprolol delivery system |
US8114883B2 (en) * | 2007-12-04 | 2012-02-14 | Landec Corporation | Polymer formulations for delivery of bioactive materials |
DE102008013701A1 (de) * | 2008-03-11 | 2009-09-17 | Lts Lohmann Therapie-Systeme Ag | Transdermales Therapeutisches System mit stabilisierter Membran |
US8231906B2 (en) | 2008-07-10 | 2012-07-31 | Noven Pharmaceuticals, Inc. | Transdermal estrogen device and delivery |
BRPI0917862A2 (pt) * | 2008-09-30 | 2015-11-24 | Teikoku Pharma Usa Inc | composições transdérmicas de donepezil com distribuição prolongada e métodos para usar as mesmas |
US8142592B2 (en) | 2008-10-02 | 2012-03-27 | Mylan Inc. | Method for making a multilayer adhesive laminate |
US20100267302A1 (en) * | 2009-04-17 | 2010-10-21 | 3M Innovative Properties Company | Silicone gel adhesive construction |
KR101670379B1 (ko) * | 2009-07-31 | 2016-10-28 | (주)씨엘팜 | 니코틴 경피 전달 패취 |
EP2729148A4 (en) | 2011-07-06 | 2015-04-22 | Parkinson S Inst | COMPOSITIONS AND METHODS FOR TREATING SYMPTOMS IN PATIENTS WITH PARKINSON'S DISEASE |
AU2012296346A1 (en) | 2011-08-18 | 2014-04-03 | Biodelivery Sciences International, Inc. | Abuse-resistant mucoadhesive devices for delivery of buprenorphine |
US9901539B2 (en) | 2011-12-21 | 2018-02-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
FR2987561B1 (fr) * | 2012-03-02 | 2014-04-11 | Pf Medicament | Dispositif transdermique comprenant des micro-particules poreuses |
AR092999A1 (es) * | 2012-10-15 | 2015-05-13 | Noven Pharma | Composiciones y metodos para la administracion transdermica de metilfenidato |
ES2621915T3 (es) | 2012-10-25 | 2017-07-05 | Noven Pharmaceuticals, Inc. | Composiciones y métodos para la administración transdérmica de anfetamina |
CN103845220B (zh) * | 2012-12-04 | 2017-09-01 | 日绊株式会社 | 贴附剂 |
CA2896055C (en) * | 2012-12-28 | 2021-02-16 | Noven Pharmaceuticals, Inc. | Compositions and methods for transdermal delivery of amphetamine and clonidine |
JP6359032B2 (ja) | 2012-12-28 | 2018-07-18 | ノーヴェン ファーマシューティカルズ インコーポレイテッド | 経皮薬物送達用のマルチポリマー組成物 |
WO2014106014A1 (en) | 2012-12-28 | 2014-07-03 | Noven Pharmaceuticals, Inc | Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol |
EP2938334A1 (en) * | 2012-12-28 | 2015-11-04 | Noven Pharmaceuticals, INC. | Compositions and methods for transdermal delivery of non-steroidal anti-inflammatory agents |
US20140276483A1 (en) * | 2013-03-14 | 2014-09-18 | Noven Pharmaceuticals, Inc. | Transdermal methylphenidate compositions with acrylic block copolymers |
US11337936B2 (en) | 2013-03-14 | 2022-05-24 | Noven Pharmaceuticals, Inc. | Amphetamine transdermal compositions with acrylic block copolymer |
AR095260A1 (es) * | 2013-03-15 | 2015-09-30 | Noven Pharma | Composiciones de anfetaminas transdérmicas estables y métodos de fabricación |
AR095259A1 (es) | 2013-03-15 | 2015-09-30 | Noven Pharma | Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria |
CN103432104B (zh) * | 2013-08-09 | 2015-10-28 | 大连理工大学 | 一种含有普拉克索的透皮贴剂 |
US20150098997A1 (en) | 2013-10-07 | 2015-04-09 | Teikoku Pharma Usa, Inc. | Methods and Compositions for Treating Attention Deficit Hyperactivity Disorder, Anxiety and Insomnia Using Dexmedetomidine Transdermal Compositions |
RU2648449C2 (ru) * | 2013-10-07 | 2018-03-26 | ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. | Способы и композиции для трансдермальной доставки неседативного количества дексмедетомидина |
KR20160096155A (ko) * | 2013-12-12 | 2016-08-12 | 히사미쓰 세이야꾸 가부시키가이샤 | 커버재가 부착된 첩부제 및 커버재가 부착된 첩부제 키트 |
EP3086783B1 (en) * | 2013-12-23 | 2018-08-29 | Noven Pharmaceuticals, INC. | Compositions and methods for transdermal delivery of amphetamine |
CA2956596A1 (en) | 2014-07-31 | 2016-02-04 | Noven Pharmaceuticals, Inc. | Silicone-containing acrylic polymers for transdermal drug delivery compositions |
CA2974324A1 (en) | 2015-01-28 | 2016-08-04 | Zita S. Netzel | Drug delivery methods and systems |
US10463737B2 (en) | 2015-01-29 | 2019-11-05 | Dow Corning Corporation | Silicone acrylate compositions and methods of preparing the same |
US10406116B2 (en) | 2015-02-06 | 2019-09-10 | Noven Pharmaceuticals, Inc. | Pressure-sensitive adhesives for transdermal drug delivery |
EP3253840B1 (en) | 2015-02-06 | 2019-07-31 | Noven Pharmaceuticals, INC. | Pressure-sensitive adhesives for transdermal drug delivery |
CA2977814A1 (en) | 2015-03-12 | 2016-09-15 | Chrono Therapeutics Inc. | Craving input and support system |
KR101897174B1 (ko) | 2016-08-17 | 2018-09-12 | (주)오스힐 | 연부조직질환 치료용 경피약물전달 촉진장치 |
JP6978417B2 (ja) * | 2016-10-07 | 2021-12-08 | トランスウェル・バイオテック・カンパニー・リミテッド | プラミペキソール経皮送達系及びその使用 |
BR112019012573A2 (pt) | 2016-12-20 | 2019-11-19 | Lts Lohmann Therapie Systeme Ag | sistema terapêutico transdérmico que contém asenapina e polissiloxano ou poli-isobutileno |
WO2018115001A1 (en) | 2016-12-20 | 2018-06-28 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine |
US20200268681A1 (en) * | 2016-12-29 | 2020-08-27 | International Bioceutical Co. LLC | Modular transdermal delivery system and associated methods of manufacture and use |
CA3049529A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
ES2881783T3 (es) | 2017-06-26 | 2021-11-30 | Lts Lohmann Therapie Systeme Ag | Sistema terapéutico transdérmico que contiene asenapina y polímero de acrílico y silicona |
JP7420797B2 (ja) | 2018-05-29 | 2024-01-23 | モーニングサイド ベンチャー インベストメンツ リミテッド | 薬剤送達の方法及びシステム |
CN112704672A (zh) | 2018-06-20 | 2021-04-27 | 罗曼治疗系统股份公司 | 含有阿塞那平的透皮治疗系统 |
WO2020092990A1 (en) * | 2018-11-02 | 2020-05-07 | Eastern Virginia Medical School | Pharmaceutical compositions and methods of making a patch formulation for transdermal delivery |
WO2021022033A1 (en) | 2019-07-30 | 2021-02-04 | Leung Kai P | Layered composite for scar treatment and prevention |
WO2022150431A2 (en) | 2021-01-07 | 2022-07-14 | Noven Pharmaceuticals, Inc. | Amphetamine carbamate compounds and methods |
AR124577A1 (es) * | 2021-01-07 | 2023-04-12 | Noven Pharma | Composiciones transdérmicas de anfetamina con bajos niveles de carbamato |
WO2023240478A1 (en) * | 2022-06-15 | 2023-12-21 | Dow Silicones Corporation | Peelable coating composition and use thereof |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5843368B2 (ja) | 1980-10-30 | 1983-09-27 | 日東電工株式会社 | 消炎鎮痛貼付剤 |
GB2105990B (en) | 1981-08-27 | 1985-06-19 | Nitto Electric Ind Co | Adhesive skin patches |
US4559222A (en) | 1983-05-04 | 1985-12-17 | Alza Corporation | Matrix composition for transdermal therapeutic system |
US4655767A (en) | 1984-10-29 | 1987-04-07 | Dow Corning Corporation | Transdermal drug delivery devices with amine-resistant silicone adhesives |
US4584355A (en) | 1984-10-29 | 1986-04-22 | Dow Corning Corporation | Silicone pressure-sensitive adhesive process and product with improved lap-shear stability-I |
US4585836A (en) | 1984-10-29 | 1986-04-29 | Dow Corning Corporation | Silicone pressure-sensitive adhesive process and product with improved lap-shear stability-II |
US4591622A (en) | 1984-10-29 | 1986-05-27 | Dow Corning Corporation | Silicone pressure-sensitive adhesive process and product thereof |
US4938759A (en) * | 1986-09-02 | 1990-07-03 | Alza Corporation | Transdermal delivery device having a rate controlling adhesive |
US4911707A (en) | 1987-02-13 | 1990-03-27 | Ciba-Geigy Corporation | Monolithic user-activated transdermal therapeutic system |
US4746515A (en) | 1987-02-26 | 1988-05-24 | Alza Corporation | Skin permeation enhancer compositions using glycerol monolaurate |
US4983395A (en) | 1987-11-12 | 1991-01-08 | Theratech Inc. | Device for administering an active agent to the skin or mucosa |
US4915950A (en) | 1988-02-12 | 1990-04-10 | Cygnus Research Corporation | Printed transdermal drug delivery device |
US4994278A (en) | 1988-03-04 | 1991-02-19 | Noven Pharmaceuticals, Inc. | Breathable backing |
US5446070A (en) | 1991-02-27 | 1995-08-29 | Nover Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
US5474783A (en) | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US4994267A (en) | 1988-03-04 | 1991-02-19 | Noven Pharmaceuticals, Inc. | Transdermal acrylic multipolymer drug delivery system |
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
DE3905050A1 (de) * | 1989-02-18 | 1990-08-30 | Lohmann Therapie Syst Lts | Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (ii) |
US5262165A (en) | 1992-02-04 | 1993-11-16 | Schering Corporation | Transdermal nitroglycerin patch with penetration enhancers |
US5271940A (en) | 1989-09-14 | 1993-12-21 | Cygnus Therapeutic Systems | Transdermal delivery device having delayed onset |
US5633009A (en) | 1990-11-28 | 1997-05-27 | Sano Corporation | Transdermal administration of azapirones |
WO1992009252A1 (en) * | 1990-11-28 | 1992-06-11 | Sano Corporation | Method and device for treating tobacco addiction |
CA2075517C (en) * | 1992-04-01 | 1997-03-11 | John Wick | Transdermal patch incorporating a polymer film incorporated with an active agent |
JP2960832B2 (ja) | 1992-05-08 | 1999-10-12 | ペルマテック テクノロジー アクチェンゲゼルシャフト | エストラジオールの投与システム |
US5622944A (en) | 1992-06-12 | 1997-04-22 | Affymax Technologies N.V. | Testosterone prodrugs for improved drug delivery |
US5462746A (en) | 1992-11-02 | 1995-10-31 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation |
GB2273044B (en) * | 1992-12-02 | 1997-04-09 | Pacific Chem Co Ltd | Medicinal patches for percutaneous administration |
JP2569396B2 (ja) * | 1992-12-04 | 1997-01-08 | 株式会社太平洋 | 経皮投与型薬物用貼付剤 |
JP3489831B2 (ja) | 1993-04-20 | 2004-01-26 | ヘクサル・アクチエンゲゼルシャフト | 活性成分パッチ |
US5762952A (en) | 1993-04-27 | 1998-06-09 | Hercon Laboratories Corporation | Transdermal delivery of active drugs |
US5567488A (en) | 1993-09-16 | 1996-10-22 | The Dow Chemical Company | Multilayer barrier film for transdermal drug delivery system and ostomy applications |
DE4332094C2 (de) * | 1993-09-22 | 1995-09-07 | Lohmann Therapie Syst Lts | Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung |
US5723145A (en) * | 1993-09-30 | 1998-03-03 | Takiron Co., Ltd. | Transdermal absorption preparation |
DE4405898A1 (de) * | 1994-02-18 | 1995-08-24 | Schering Ag | Transdermale therapeutische Systeme enthaltend Sexualsteroide |
US5474787A (en) | 1994-10-21 | 1995-12-12 | The Wm. Wrigley Jr. Company | Chewing gum containing a lecithin/glycerol triacetate blend |
FR2728463A1 (fr) * | 1994-12-21 | 1996-06-28 | Lhd Lab Hygiene Dietetique | Systeme transdermique d'administration simultanee de plusieurs principes actifs |
NZ309980A (en) | 1995-06-07 | 2001-06-29 | Noven Pharma | Transdermal composition containing a blend of one or more polymers, one or more drugs that has a low molecular weight and is liquid at room temperature |
US5906830A (en) | 1995-09-08 | 1999-05-25 | Cygnus, Inc. | Supersaturated transdermal drug delivery systems, and methods for manufacturing the same |
US5902603A (en) | 1995-09-14 | 1999-05-11 | Cygnus, Inc. | Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use |
FR2749586B1 (fr) * | 1996-06-11 | 1998-08-07 | Hoechst Marion Roussel Inc | Nouveaux dispositifs destines a l'administration transdermique de la trimegestone, leur procede de preparation et leur application a titre de medicaments |
EP1014981A1 (en) * | 1997-02-07 | 2000-07-05 | Synapse Pharmaceuticals International, Inc. | Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime |
DE19738855C2 (de) | 1997-09-05 | 2001-01-04 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit haftklebender Reservoirschicht und unidirektional elastischer Rückschicht |
AU750809B2 (en) | 1997-09-26 | 2002-07-25 | Noven Pharmaceuticals, Inc. | Bioadhesive compositions and methods for topical administration of active agents |
US6210705B1 (en) | 1997-12-15 | 2001-04-03 | Noven Pharmaceuticals, Nc. | Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
DE69916492T3 (de) * | 1998-12-07 | 2008-08-14 | J. Dev Ltd., Athlone | Pflaster zur transdermalen applikation von flüchtigen, flüssigen wirkstoffen |
EP1449527A3 (en) | 1998-12-07 | 2004-09-08 | Elan Pharma International Limited | Transdermal patch for administering a volatile liquid drug |
US20030170195A1 (en) * | 2000-01-10 | 2003-09-11 | Noven Pharmaceuticals, Inc. | Compositions and methods for drug delivery |
KR20010036685A (ko) | 1999-10-11 | 2001-05-07 | 김윤 | 펜타닐을 함유하는 매트릭스형 경피투여제 |
DE19950066A1 (de) | 1999-10-16 | 2001-04-26 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut |
IL149655A0 (en) * | 1999-11-24 | 2002-11-10 | Agile Therapeutics Inc | Improved transdermal contraceptive delivery system and process |
AU9505801A (en) | 2000-09-24 | 2002-04-02 | 3M Innovative Properties Co | Drying method for selectively removing volatile components from wet coatings |
US6828351B2 (en) * | 2000-11-01 | 2004-12-07 | Sention, Inc. | Methods and compositions for regulating memory consolidation |
US6448303B1 (en) | 2000-12-29 | 2002-09-10 | National Starch And Chemical Investment Holding Corporation | Hot melt adhesives for dermal application |
JP4323138B2 (ja) | 2002-06-05 | 2009-09-02 | 日東電工株式会社 | 経皮吸収型製剤およびその製造方法 |
WO2005025549A2 (en) | 2003-09-10 | 2005-03-24 | Noven Pharmaceuticals, Inc. | Multi-layer transdermal drug delivery device |
US20050202073A1 (en) * | 2004-03-09 | 2005-09-15 | Mylan Technologies, Inc. | Transdermal systems containing multilayer adhesive matrices to modify drug delivery |
WO2006041907A2 (en) | 2004-10-08 | 2006-04-20 | Noven Pharmaceuticals, Inc. | Transdermal delivery of estradiol |
-
2004
- 2004-10-28 UA UAA200605792A patent/UA84303C2/ru unknown
- 2004-10-28 ES ES04810038.2T patent/ES2626784T3/es active Active
- 2004-10-28 JP JP2006538197A patent/JP2007509951A/ja active Pending
- 2004-10-28 US US10/975,043 patent/US8703175B2/en active Active
- 2004-10-28 CA CA2542778A patent/CA2542778C/en active Active
- 2004-10-28 ME MEP-2008-235A patent/ME00114B/me unknown
- 2004-10-28 RU RU2006118341/15A patent/RU2356580C2/ru not_active IP Right Cessation
- 2004-10-28 EP EP04810038.2A patent/EP1682061B1/en active Active
- 2004-10-28 RS YUP-2006/0332A patent/RS20060332A/sr unknown
- 2004-10-28 AU AU2004285505A patent/AU2004285505B2/en not_active Ceased
- 2004-10-28 KR KR1020067010411A patent/KR20060114338A/ko not_active Application Discontinuation
- 2004-10-28 WO PCT/US2004/035556 patent/WO2005042055A2/en active Application Filing
- 2004-10-28 GE GEAP20049414A patent/GEP20084561B/en unknown
- 2004-10-28 NZ NZ546992A patent/NZ546992A/xx not_active IP Right Cessation
- 2004-10-28 ME MEP-235/08A patent/MEP23508A/xx unknown
- 2004-10-28 CN CNB2004800392144A patent/CN100457064C/zh not_active Expired - Fee Related
- 2004-10-28 BR BRPI0416063-0A patent/BRPI0416063A/pt not_active Application Discontinuation
-
2006
- 2006-04-10 IL IL174894A patent/IL174894A0/en unknown
- 2006-04-25 ZA ZA200603300A patent/ZA200603300B/en unknown
- 2006-05-29 NO NO20062434A patent/NO20062434L/no not_active Application Discontinuation
-
2010
- 2010-06-03 US US12/792,940 patent/US20100310610A1/en not_active Abandoned
-
2013
- 2013-07-31 JP JP2013159844A patent/JP2013237691A/ja active Pending
-
2014
- 2014-02-27 US US14/191,900 patent/US20140243764A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
RS20060332A (en) | 2008-04-04 |
JP2013237691A (ja) | 2013-11-28 |
CN100457064C (zh) | 2009-02-04 |
JP2007509951A (ja) | 2007-04-19 |
MEP23508A (en) | 2010-06-10 |
RU2006118341A (ru) | 2007-12-20 |
WO2005042055A3 (en) | 2005-08-25 |
CA2542778A1 (en) | 2005-05-12 |
US20050169977A1 (en) | 2005-08-04 |
IL174894A0 (en) | 2006-08-20 |
WO2005042055A2 (en) | 2005-05-12 |
NZ546992A (en) | 2009-07-31 |
US20140243764A1 (en) | 2014-08-28 |
EP1682061A2 (en) | 2006-07-26 |
US20100310610A1 (en) | 2010-12-09 |
AU2004285505A1 (en) | 2005-05-12 |
BRPI0416063A (pt) | 2007-01-02 |
ME00114B (me) | 2011-02-10 |
RU2356580C2 (ru) | 2009-05-27 |
GEP20084561B (en) | 2008-12-10 |
EP1682061B1 (en) | 2017-03-15 |
UA84303C2 (ru) | 2008-10-10 |
ES2626784T3 (es) | 2017-07-26 |
KR20060114338A (ko) | 2006-11-06 |
CA2542778C (en) | 2012-05-29 |
EP1682061A4 (en) | 2011-12-07 |
US8703175B2 (en) | 2014-04-22 |
AU2004285505B2 (en) | 2010-12-23 |
ZA200603300B (en) | 2007-07-25 |
CN1901861A (zh) | 2007-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20062434L (no) | Sammensetninger og fremgangsmater til a kontrollere legemiddeltap og -levering i transdermale legemiddelleveringssystemer | |
TW200628175A (en) | Transdermal drug delivert device including an occlusive backing | |
DE50112720D1 (de) | Transdermales therapeutisches system mit hochdispersem siliziumdioxid | |
BRPI0417437A (pt) | dispositivo para inibição da absorção, dispositivo para remoção de agente fisiologicamente ativo e dispositivo para redução do efeito de overdose | |
HRP20050828B1 (hr) | Uv-stabilni transdermalni flaster | |
CY1105138T1 (el) | Θepμου-τηγματος-δθς για χορηγηση ροτιγκοτινης | |
BR0209466A (pt) | Dispositivo, sistema e método para suprir pelo menos um agente ativo a uma superfìcie corporal localizada, e, método para produzir um dispositivo para suprimento de pelo menos um agente ativo a uma superfìcie corporal localizada | |
DK0674913T3 (da) | Ikke-okklusivt klæbende plaster til påföring af medicament i huden | |
HK1083009A1 (en) | Topical drug delivery using phosphatidylcholine | |
DE69326461D1 (de) | Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung | |
WO2001003917A3 (de) | Wirkstoffhaltigen mehrschichtfilm aus in situ vernetzten hydrophilen polymeren | |
BR0114628A (pt) | Membro de retenção em microprojeção para aplicador de impacto | |
CA2414239A1 (en) | Analgesic anti-inflammatory patch for topical application | |
TW570815B (en) | Transdermal therapeutic system (TTS) containing the active substance fentanyl | |
DE69923348D1 (de) | Transdermales arzneistoffverabreichungssystem | |
ATE262928T1 (de) | Substrate für heftpflaster | |
ES2165232T3 (es) | Sistema terapeutico transdermico (tts) que contiene oxibutinina. | |
WO2001026637A3 (de) | Transdermales therapeutisches system zur abgabe von acetylsalicylsäure und/oder salicylsäure | |
DK1251853T3 (da) | Transdermalt terapeutisk system til indgivelse af zaleplon | |
NO20031211L (no) | Plaster omfattende diclofenac | |
ATE214606T1 (de) | Transdermales therapeutisches system mit dem wirkstoff scopolaminbase | |
BRPI0405662A (pt) | Emplastros contendo turobuterol | |
ES2141548T3 (es) | Preparado farmaceutico de superficie estabilizada para su aplicacion sobre la piel. | |
GB2380526A (en) | Improvements in and relating to methods and apparatus for the application of honey to wounds | |
HUP0302830A2 (hu) | Transzdermális gyógyszerkészítmény |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |